Please use this identifier to cite or link to this item:
Title: A circulating miRNA signature for stratification of breast lesions among women with abnormal screening mammograms
Authors: Loke, S.Y. 
Munusamy, P.
Koh, G.L.
Chan, C.H.T.
Madhukumar, P 
Thung, J.L.
Tan, K.T.B. 
Ong, K.W.
Yong, W.S. 
Sim, Y. 
Oey, C.L.
Lim, S.Z. 
Chan, M.Y.P.
Ho, T.S.J. 
Khoo, B.K.J. 
Wong, S.L.J.
Thng, C.H. 
Chong, B.K.
Tan, E.Y.
Tan, V.K.-M. 
Lee, A.S.G. 
Keywords: Blood-based test
Breast cancer
Circulating microRNAs
Liquid biopsies
Molecular diagnosis
Issue Date: 2019
Publisher: MDPI AG
Citation: Loke, S.Y., Munusamy, P., Koh, G.L., Chan, C.H.T., Madhukumar, P, Thung, J.L., Tan, K.T.B., Ong, K.W., Yong, W.S., Sim, Y., Oey, C.L., Lim, S.Z., Chan, M.Y.P., Ho, T.S.J., Khoo, B.K.J., Wong, S.L.J., Thng, C.H., Chong, B.K., Tan, E.Y., Tan, V.K.-M., Lee, A.S.G. (2019). A circulating miRNA signature for stratification of breast lesions among women with abnormal screening mammograms. Cancers 11 (12) : 1872. ScholarBank@NUS Repository.
Rights: Attribution 4.0 International
Abstract: Although mammography is the gold standard for breast cancer screening, the high rates of false-positive mammograms remain a concern. Thus, there is an unmet clinical need for a non-invasive and reliable test to dierentiate between malignant and benign breast lesions in order to avoid subjecting patients with abnormal mammograms to unnecessary follow-up diagnostic procedures. Serum samples from 116 malignant breast lesions and 64 benign breast lesions were comprehensively profiled for 2,083 microRNAs (miRNAs) using next-generation sequencing. Of the 180 samples profiled, three outliers were removed based on the principal component analysis (PCA), and the remaining samples were divided into training (n = 125) and test (n = 52) sets at a 70:30 ratio for further analysis. In the training set, significantly dierentially expressed miRNAs (adjusted p <0.01) were identified after correcting for multiple testing using a false discovery rate. Subsequently, a predictive classification model using an eight-miRNA signature and a Bayesian logistic regression algorithm was developed. Based on the receiver operating characteristic (ROC) curve analysis in the test set, the model could achieve an area under the curve (AUC) of 0.9542. Together, this study demonstrates the potential use of circulating miRNAs as an adjunct test to stratify breast lesions in patients with abnormal screening mammograms. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.
Source Title: Cancers
ISSN: 20726694
DOI: 10.3390/cancers11121872
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3390_cancers11121872.pdf1.57 MBAdobe PDF



Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons